Integrate Five BioTechs At Once
Integrate Five BioTechs At Once In 2022 KKR invested with Ampersand in Biosynth and four other Biotech companies in Europe and the U.S. to create a platform for a new Life Sciences company The task: Produce and execute a business and technology integration plan for five companies at the same time with four different close dates. This included communications, day 1 planning, […]
Integrate Five BioTechs At Once Read More »